肺炎支原体感染诱发的小儿哮喘中西医结合治疗的回顾性临床分析

目的:探讨肺炎支原体感染诱发小儿哮喘的临床特点及中西医结合治疗的回顾性临床分析。方法:回顾性分析我院2015年5月—2017年5月收治的70例小儿哮喘患者临床资料,分为肺炎支原体感染的观察组(40例)与非肺炎支原体感染的对照组(30例),观察两组临床表现及中西医结合治疗的临床效果。结果:观察组发热、肺部炎症、肺部哮鸣音、间质性肺炎等发生率均显著高于对照组,治疗后,观察组疗效优于对照组,复发率低于对照组,比较均P<0.05。结论:肺炎支原体感染诱发的小儿哮喘与普通哮喘临床特征显著不同,采用布地奈德混悬液雾化吸入,大环内酯类抗生素及辅以中药治疗,疗效显著,复发率低,值得临床推广应用。

objective: to investigate the clinical features of mycoplasma pneumoniae infection induced asthma in children and the retrospective clinical analysis of the combination of Chinese and western medicine. Methods: a retrospective analysis in May 2015-May 2017 clinical data of 70 cases of pediatric asthma, divided into pneumonia mycoplasma infection of observation group(40 cases) and non pneumonia mycoplasma infection control group(30 cases), observe two groups of clinical symptoms and the clinical effect of combined Chinese and western medicine treatment. Results: the observation group of fever, lung inflammation, lung wheezing sound, such as interstitial pneumonia incidence were significantly higher than that of control group, after treatment, the observation group curative effect is better than that of control group, the recurrence rate is lower than the control group, comparing all P< 0.05. Conclusion: mycoplasma pneumoniae infection of pediatric asthma induced asthma and common clinical features significantly different, with budesonide suspension liquid atomization inhalation, large ring lactone class antibiotic and supplemented by traditional Chinese medicine treatment, the curative effect is distinct, the recurrence rate is low, worthy of clinical popularization and application.